The pro-apoptotic effect of cysteinyl leukotriene receptor (CysLT-R) antagonist montelukast is mediated by CysLT-Rs expression on antigen-stimulated T cells Source: Eur Respir J 2003; 22: Suppl. 45, 100s Year: 2003
The effects of a cysteinyl leukotriene receptor antagonist, pranlukast, on dendritic cell chemoattractants in the airways of subjects with asthma Source: Eur Respir J 2004; 24: Suppl. 48, 132s Year: 2004
The effect of a leukotriene antagonist, pranlukast, on allergen-induced airway responses and circulating dendritic cells in subjects with atopic asthma Source: Eur Respir J 2003; 22: Suppl. 45, 414s Year: 2003
The up-regulation of cysteinyl-leukotriene receptors on T cells Source: Eur Respir J 2003; 22: Suppl. 45, 395s Year: 2003
Anti-inflammatory effects of roflumilast N-oxide and dexamethasone in human bronchial epithelial cells stimulated with toll-like receptor agonists Source: Annual Congress 2013 –The pulmonary epithelium: recent developments Year: 2013
Effect of leukotriene receptor antagonist on expression and variation of TGF-beta in T lymphocyte for mild persistent asthma in children Source: Annual Congress 2011 - Treating childhood asthma Year: 2011
The CysLT1 receptor antagonist montelukast inhibits mast cell activation induced by inhaled leukotriene E4 in subjects with asthma Source: International Congress 2016 – Clinical and molecular studies in asthma Year: 2016
The Cys-LT1 receptor antagonist, pranlukast, attenuates allergen-induced increase in airway eosinophils and bone marrow derived eosinophil/basophil progenitors in subjects with atopic asthma Source: Eur Respir J 2003; 22: Suppl. 45, 349s Year: 2003
SCH 527123, a CXCR2 antagonist, inhibits ozone-induced airway neutrophilia in healthy subjects Source: Annual Congress 2007 - New drugs for COPD Year: 2007
Effects of formoterol and salmeterol on the production of Th1- and Th2-related chemokines by monocytes and bronchial epithelial cells Source: Eur Respir J 2008; 31: 1313-1321 Year: 2008
Effects of long-acting beta2 agonists on Th1 and Th2 chemokines in monocytes and bronchial epithelial cells Source: Annual Congress 2008 - Novel therapeutic approaches and immunological mechanisms in airway cell pathobiology Year: 2008
A leukotriene antagonist, montelukast, reduces in vitro LTD4 increases in peripheral blood eosinophil progenitor colonies in atopic subjects Source: Eur Respir J 2001; 18: Suppl. 33, 531s Year: 2001
Inhibition of the asthmatic allergen challenge response by the CRTH2 antagonist OC000459 Source: Eur Respir J 2013; 41: 46-52 Year: 2013
Effects of roflumilast and other PDE4 inhibitors on human CD8+ T-cell functions Source: Eur Respir J 2005; 26: Suppl. 49, 716s Year: 2005
A CXCR2 antagonist inhibits polyI:C-induced airway neutrophil, but not lymphocyte infiltrate Source: Annual Congress 2011 - Anti-inflammatory strategies in acute lung injury Year: 2011
Differing effects of montelukast and ketotifen on cytokine expression in human myeloid dendritic cells Source: Annual Congress 2010 - Regulation of airway pharmacology Year: 2010
Effect of AVE5883, a dual NK1/NK2 receptor antagonist, on airway responsiveness to neurokinin A in asthma Source: Eur Respir J 2004; 24: Suppl. 48, 219s Year: 2004
Effects of a newly developed dual CysLT1 and CysLT2 receptor antagonist, ONO-RS-531, on antigen- and leukotriene D4 -induced contractions of isolated human bronchi Source: Eur Respir J 2005; 26: Suppl. 49, 214s Year: 2005
Fevipiprant antagonises prostaglandin D2-induced activation of type-2 CD8 T cells (Tc2) Source: International Congress 2019 – Novel targets and mechanisms in asthma Year: 2019
The effect of specific Hymenoptera VIT using the ultra-rush method on immunoregulatory properties of T and B Lymphocytes, histamine, tryptase and serum cytokine concentrations. Source: Virtual Congress 2020 – Management of allergy, asthma and COPD Year: 2020